CadyB.Natural history of primary and secondary tumors of the liver. Semin. Oncol., 10: 127–133, 1983.
2.
TaylorI.Liver metastases from colorectal cancer: lesson from past and present clinical studies. Br. J. Surg., 83: 456–460, 1996.
3.
FidlerI.J., RadinskyR.: Genetic control of cancer metastasis. J. Natl. Cancer Inst., 82: 166–168, 1990.
4.
LongL., NipJ., BrodtP.: Paracrine growth stimulation by hepatocyte-derived insuline-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res., 54: 3732–3737, 1994.
5.
GutmanM., SinghR.K., PriceJ.E., FanD., FidlerI.J.: Accelerated growth of human colon cancer cells in nude mice under going liver regeneration. Invasion Metastasis, 14: 362–371, 1994–1995.
RadinskyR., RisinS., FanD.: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res., 1: 19–31, 1995.
KronawitterU., KemenyN.E., HeelanR., FataF., FongY.: Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer, 86: 229–235, 1999.
14.
TakadaT., AmmoriB.J., YoshidaM., AmanoH., YasudaH., TakeshitaK., KoutakeH., TakadaK., MiyakawaS.: Combined preoperative embolization of the right portal vein and hepatic artery for hepatic resection in a high-risk patient. AJR Am. J. Roentgenol., 173: 165–167, 1999.
15.
HustinxR., PaulusP., JacquetN., JerusalemG., BuryT., RigoP.: Clinical evaluation of whole-body 18F-fluo-rodeoxyglucose positron emission tomography in the detection of liver metastases. Ann. Oncol., 9: 397–401, 1998.
16.
RahusenF.D., CuestaM.A., BorgsteinP.J., BleichrodtR.P., BarkhofF., DoesburgT., MeijerS.: Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann. Surg., 230: 31–37, 1999.
17.
TsaoJ., LoftusJ., NagorneyD., AdsonM.A., IlstrupD.M.: Trends in morbidity and mortality of hepatic resection for malignancy. Ann. Surg.220: 199, 1994.
18.
D'AngelicaM., BrennanM.F., FortnerJ.G., CohenA.M., BlumgartL.H., FongY.: Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J. Am. Coll. Surg., 185: 554–559, 1997.
19.
TaylorM., ForsterJ., LangerB., TaylorB.R., GreigP.D., MahutC.: A study of prognostic factors for hepatic resection for colorectal metastases. Am. J. Surg., 173: 467–471, 1997.
20.
BlumgartL.H., FongY.: Surgical options in the treatment of hepatic metastases from colorectal cancer. Curr. Probl. Surg., 32: 335–421, 1995.
21.
KemenyN., CohenA., HuangY., ShiW., BlumgartL., Turn-bullA., SullivanD., StockmanJ.: Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus SYS alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer [Abstract 1011]. Proc. Am. Soc. Clin. Oncol., 18: 263a (abst 1011).
22.
EliasD., Cavalcanti de AlbuquerqueA., EggenspielerP., PlaudB., DucreuxM., SpielmannM., TheodoreC., BonvalotS., LasserP.: Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial chemotherapy for initially unresectable hepatic tumors. J. Am. Coll. Surg., 180: 213–219, 1995.
23.
ShafirM., ShapiroR., SungM., WarnerR., SicularA., KlipfelA.: Cryoablation of unresectable malignant liver tumors. Am. J. Surg., 171: 27–31, 1996.
24.
CurleyS.A., IzzoF., DelrioP., EllisL.M., GranchiJ., ValloneP., FioreF., PignataS., DanieleB., CremonaF.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann. Surg., 230: 1–8, 1999.
25.
AdamR., AkpinarE., JohannM., KunstlingerF., MajnoP., BismuthH.: Place of cryosurgery in the treatment of malignant liver tumors. Ann. Surg., 225: 39–50, 1997.
26.
CuschieriA., CrosthwaiteG., ShimiS., PietrabissaA., JoypaulV., TairI., NaziriW.: Hepatic cryotherapy for liver tumors: development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use. Surg. Endosc., 9: 483–489, 1995.
27.
RavikumarT.S.: Interstitial therapies for liver tumors. Surg. Onc. Clin. N. Amer., 5: 365–378, 1996.
28.
SteeleG.: Cryoablation in hepatic surgery. Sem. Liv. Dis., 14: 120–125, 1994.
29.
WeaverM.L., AshtonJ.G., ZemelR.: Treatment of colorectal liver metastases by cryotherapy. Sem. Surg. Onc., 14: 163–170, 1998.
30.
JiaoL.R., HansenP.D., HavlikR., MitryR.R., PignatelliM., HabibN.: Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am. J. Surg., 177: 303–306, 1999.
31.
CurleyS.A., IzzoF., DelrioP., EllisL.M., GranchiJ., ValloneP., FioreF., PignataS., DanieleB., CremonaF.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann. Surg., 230: 1–8, 1999.
32.
ScudamoreC.H., LeeS.I., PattersonE.J., BuczkowskiA.K., JulyL.V., ChungS.W., BuckleyA.R., HoS.G., OwenD.A.: Radiofrequency ablation followed by resection of malignant liver tumors. Am. J. Surg., 177: 411–417, 1999.
33.
GeogheganJ.G., ScheeleJ.: Treatment of colorectal liver metastases. Br. J. Surg., 86: 158–169, 1999.
